https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/accounts-and-other-receivables-net-current https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/accounts-payable-and-accrued-liabilities-current https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/accounts-payable-other-current https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/accounts-payable-related-parties-current-and-noncurrent https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/accounts-payable-trade-current https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/accounts-receivable https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/accrued-bonuses-current https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/accrued-liabilities-current https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/accrued-salaries-current https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/accumulated-depreciation https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/additional-paid-in-capital https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/allowance-for-doubtful-accounts-receivable-current https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/allowance-for-doubtful-accounts-receivable-write-offs https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/aoci https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/assets-noncurrent https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/available-for-sale-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/available-for-sale-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/available-for-sale-amortized-cost https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/available-for-sale-current https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/available-for-sale-debt-maturities-within-one-year-fair-value https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/available-for-sale-debt-securities https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/available-for-sale-gross-realized-gain-loss-excluding-other-than-temporary-impairments https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/available-for-sale-noncurrent https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/available-for-sale-restricted-noncurrent https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/available-for-sale-securities https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/capital-expenditures https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/cash-and-equivalents https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/cash-and-restricted-cash https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/cash-and-restricted-cash-change-excluding-exchange-rate-effect https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/cash-and-restricted-cash-including-disposal-group-and-discontinued-operations https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/cash-cash-equivalents-and-short-term-investments https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/cash-flow-breakdown https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/common-stock-value https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/comprehensive-income https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/concept-stock-issued-tag-2 https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/conversion-of-stock-amount-converted https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/convertible-debt-noncurrent https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/cost-of-revenue https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/costs-and-expenses https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/cover-page-shares-outstanding https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/current-assets https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/current-liabilities https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/current-portion-of-long-term-debt https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/debt-conversion-converted-instrument-amount https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/debt-fair-value https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/debt-unamortized-discount-noncurrent https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/deferred-finance-costs-net https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/deferred-revenue https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/deferred-tax-assets-in-process-research-and-development https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/deferred-tax-assets-other https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/defined-benefit-plan-contributions-by-employer https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/deposits-assets https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/depreciation-and-amortization https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/derivative-amount-of-hedged-item https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/derivative-assets https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/derivative-assets-current https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/derivative-fair-value-of-derivative-net https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/derivative-gain-on-derivative https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/derivative-liabilities https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/derivative-liabilities-current https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/effect-of-exchange-rate-on-cash-and-cash-equivalents https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/effect-of-exchange-rate-on-cash-and-restricted-cash https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/employee-related-liabilities-current https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/fair-value-inputs-discount-rate https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/finance-lease-right-of-use-asset https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/financing-cash-flow https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/foreign-currency-transaction-gain-loss-before-tax https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/gain-loss-on-disposition-of-assets https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/gross-profit https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/income-tax https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/income-taxes-paid https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/increase-decrease-in-accounts-and-other-receivables https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/increase-decrease-in-inventories https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/increase-decrease-in-other-noncurrent-assets https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/increase-decrease-in-other-noncurrent-liabilities https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/insider-transactions-stock-options https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/insider-transactions-stock-units https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/insider-transactions-warrants https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/interest-expense-long-term-debt https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/interest-expense-on-debt https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/interest-income-deposits-with-financial-institutions https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/interest-paid-net https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/inventory https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/inventory-finished-goods https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/inventory-raw-materials-and-supplies https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/investing-cash-flow https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/investments-fair-value-disclosure https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/labor-and-related-expense https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/liabilities-noncurrent https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/license-and-services-revenue https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/line-of-credit-facility-commitment-fee-percentage https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/line-of-credit-facility-interest-rate https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/line-of-credit-facility-maximum-borrowing-capacity https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/loans-payable-to-bank-current https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/long-term-debt https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/long-term-loans-from-bank https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/marketable-securities https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/marketable-securities-current https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/marketable-securities-gain-loss https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/marketable-securities-noncurrent https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/marketable-securities-restricted https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/marketable-securities-restricted-current https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/marketable-securities-restricted-noncurrent https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/marketable-securities-unrealized-gain-loss https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/marketable-securities-unrealized-gain-loss-excluding-other-than-temporary-impairments https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/net-cash-from https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/net-cash-from-financing-activities https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/net-cash-from-investing-activities https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/net-cash-from-operating-activities https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/net-change-in-cash https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/net-income https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/oci-foreign-currency-transaction-and-translation-gain-loss-arising-net-of-tax https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/oci-net-of-tax https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/oci-reclassification-adjustment-from-aoci-for-sale-of-securities-net-of-tax https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/oci-reclassification-adjustment-from-aoci-on-derivatives-net-of-tax https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/oci-unrealized-gain-loss-on-derivatives-arising-net-of-tax https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/oci-unrealized-holding-gain-loss-on-securities-arising-net-of-tax https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/operating-cash-flow https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/operating-income https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/operating-lease-assets https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/operating-lease-expense https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/operating-lease-liability https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/operating-lease-liability-current https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/operating-lease-payments https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/operating-lease-payments-due https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/operating-lease-payments-due-2 https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/operating-lease-payments-due-current https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/operating-lease-variable-lease-income https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/operating-leases-rent-expense-net https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/operating-loss-carryforwards https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/other-accrued-liabilities-current https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/other-assets-miscellaneous-noncurrent https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/other-liabilities https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/other-long-term-investments https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/other-noncash-expense https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/other-noncash-income-expense https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/other-noncurrent-assets https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/other-research-and-development-expense https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/other-selling-general-and-administrative-expense https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/other-short-term-investments https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/other-significant-noncash-transaction-value-of-consideration-received https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/paid-in-capital-shares-issued-issuance-costs https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/payments-for-merger-related-costs https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/payments-to-acquire-available-for-sale-securities https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/payments-to-acquire-investments https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/payments-to-acquire-marketable-securities https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/payments-to-acquire-other-investments https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/pension-and-other-postretirement-benefit-expense https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/pretax-income https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/proceeds-from-bank-debt https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/proceeds-from-contributions-from-parent https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/proceeds-from-convertible-debt https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/proceeds-from-sale-and-maturity-of-available-for-sale-securities https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/proceeds-from-sale-and-maturity-of-marketable-securities https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/proceeds-from-sale-of-available-for-sale-securities https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/proceeds-from-sale-of-property-held-for-sale https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/proceeds-from-sale-of-trading-securities-heldforinvestment https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/proceeds-from-stock-issued https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/property-plant-and-equipment-gross https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/property-plant-equipment https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/public-float https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/realized-gains-on-securities https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/repayments-of-bank-debt https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/repayments-of-other-debt https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/research-and-development https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/research-and-development-in-process https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/restricted-cash-and-cash-equivalents https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/restricted-cash-and-cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/restricted-investments https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/restricted-investments-current https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/restricted-investments-noncurrent https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/retained-earnings https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/revenue https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/royalty-revenue https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/severance-costs https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/sga-expense https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/share-price https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/shareholders-equity https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/shares-authorized https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/shares-issued https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/stock-and-warrants-issued-value-preferred-stock-and-warrants https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/stock-award-number-of-shares-authorized https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/stock-award-number-of-shares-available-for-grant https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/stock-based-compensation https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/stock-issued-new-shares-sold https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/stock-issued-shares-issued-value-employee-stock-ownership-plan https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/stock-issued-shares-issued-value-other https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/stock-issued-value-of-shares-issued-for-stock-awards https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/stock-split-ratio https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/supplemental-unemployment-benefits-severance-benefits https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/tax-rate-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/tax-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/tax-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/tax-reconciliation-other-adjustments https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/tax-withholding-on-stock-awards https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/total-assets https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/total-liabilities https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/total-liabilities-and-equity https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/unrecognized-tax-benefits https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/utb-decrease-from-current-year-positions https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/utb-decrease-from-prior-year-positions https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/utb-increase-from-current-year-positions https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/foamix-pharmaceuticals-ltd/weighted-average-number-of-share-outstanding-basic-and-diluted